- Home
- CLIR vs KYNB Comparison
CLIR vs KYNB Comparison
Compare CLIR & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLIR | KYNB |
|---|---|---|
| Founded | 2008 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.6M | 31.9M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLIR | KYNB |
|---|---|---|
| Price | $0.57 | $7.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 78.3K | 39.0K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $530,000.00 | N/A |
| Revenue This Year | $13.13 | N/A |
| Revenue Next Year | $143.88 | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.46 | $6.95 |
| 52 Week High | $1.12 | $9.58 |
Technical Indicators
Market Signals| Indicator | CLIR | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 35.54 |
| Support Level | $0.51 | N/A |
| Resistance Level | $0.62 | $8.89 |
| Average True Range (ATR) | 0.04 | 0.55 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 10.21 | 4.13 |
Price Performance
Historical ComparisonAbout CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.